213 related articles for article (PubMed ID: 21466771)
1. Diagnosis and treatment of Helicobacter pylori infection.
Bytzer P; Dahlerup JF; Eriksen JR; Jarbøl DE; Rosenstock S; Wildt S;
Dan Med Bull; 2011 Apr; 58(4):C4271. PubMed ID: 21466771
[TBL] [Abstract][Full Text] [Related]
2. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Avidan B; Melzer E; Keller N; Bar-Meir S
Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
[TBL] [Abstract][Full Text] [Related]
3. Guidelines in the medical treatment of Helicobacter pylori infection.
Dzieniszewski J; Jarosz M
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():143-54. PubMed ID: 17033112
[TBL] [Abstract][Full Text] [Related]
4. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM
Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
[TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Laine L; Estrada R; Trujillo M; Emami S
Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
[TBL] [Abstract][Full Text] [Related]
6. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
[TBL] [Abstract][Full Text] [Related]
7. Treatment strategies for Helicobacter pylori infection.
Damianos AJ; McGarrity TJ
Am Fam Physician; 1997 Jun; 55(8):2765-74, 2784-6. PubMed ID: 9191460
[TBL] [Abstract][Full Text] [Related]
8. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
[TBL] [Abstract][Full Text] [Related]
9. Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
Uygun A; Ozel AM; Yildiz O; Aslan M; Yesilova Z; Erdil A; Bagci S; Gunhan O
J Gastroenterol Hepatol; 2008 Jan; 23(1):42-5. PubMed ID: 17559359
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.
Guevara B; Cogdill AG
Dig Dis Sci; 2020 Jul; 65(7):1917-1931. PubMed ID: 32170476
[TBL] [Abstract][Full Text] [Related]
11. Management of Helicobacter pylori infection.
Costa F; D'Elios MM
Expert Rev Anti Infect Ther; 2010 Aug; 8(8):887-92. PubMed ID: 20695744
[TBL] [Abstract][Full Text] [Related]
12. What is the impact of Helicobacter pylori density on the success of eradication therapy: a clinico-histopathological study.
Onal IK; Gokcan H; Benzer E; Bilir G; Oztas E
Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):642-6. PubMed ID: 23796974
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
14. [Helicobacter pylori infection. The Spanish consensus report. The Spanish Consensus Conference Group].
Sainz R; Borda F; Domínguez E; Gisbert JP
Rev Esp Enferm Dig; 1999 Nov; 91(11):777-84. PubMed ID: 10601771
[TBL] [Abstract][Full Text] [Related]
15. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
[TBL] [Abstract][Full Text] [Related]
16. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
van der Wouden EJ; Thijs JC; van Zwet AA; Kooy A; Kleibeuker JH
Am J Gastroenterol; 1998 Aug; 93(8):1228-31. PubMed ID: 9707042
[TBL] [Abstract][Full Text] [Related]
17. Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
Bojarski C; Epple HJ; Kirstein FW; Fromm M; Bisson S; Riecken EO; Schulzke JD
Z Gastroenterol; 2000 Mar; 38(3):211-9. PubMed ID: 10768243
[TBL] [Abstract][Full Text] [Related]
18. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of Helicobacter pylori infections--how, when and in whom?].
Wildner-Christensen M; Schaffalitzky de Muckadell OB
Ugeskr Laeger; 2000 Jun; 162(26):3743-7. PubMed ID: 10925639
[TBL] [Abstract][Full Text] [Related]
20. Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori.
Taylor JL; Zagari M; Murphy K; Freston JW
Arch Intern Med; 1997 Jan; 157(1):87-97. PubMed ID: 8996045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
